Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsConstruction in ProgressCurrent AssetsCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsCurrent TaxesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Total Debt (2017 - 2026)

Dr Reddys Laboratories has reported Total Debt over the past 10 years, most recently at $133.5 million for Q1 2026.

  • For Q1 2026, Total Debt fell 74.82% year-over-year to $133.5 million; the TTM value through Mar 2026 reached $133.5 million, down 74.82%, while the annual FY2026 figure was $133.5 million, 30.87% up from the prior year.
  • Total Debt for Q1 2026 was $133.5 million at Dr Reddys Laboratories, down from $530.2 million in the prior quarter.
  • Over five years, Total Debt peaked at $530.2 million in Q1 2025 and troughed at $87.9 million in Q1 2024.
  • A 5-year average of $258.7 million and a median of $133.5 million in 2026 define the central range for Total Debt.
  • Biggest five-year swings in Total Debt: crashed 75.85% in 2023 and later soared 503.36% in 2025.
  • Year by year, Total Debt stood at $436.6 million in 2022, then crashed by 75.85% to $105.4 million in 2023, then fell by 16.67% to $87.9 million in 2024, then skyrocketed by 503.36% to $530.2 million in 2025, then plummeted by 74.82% to $133.5 million in 2026.
  • Business Quant data shows Total Debt for RDY at $133.5 million in Q1 2026, $530.2 million in Q1 2025, and $87.9 million in Q1 2024.